Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-08 Purchase | 2024-04-10 8:38 pm | Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director | 3,086 | $8.9613 | $27,655 | 10,000 (Direct) | View |
| 2024-03-28 Purchase | 2024-04-01 7:00 pm | Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director | 6,914 | $8.4759 | $58,602 | 6,914 (Direct) | View |
| 2024-02-23 Purchase | 2024-02-27 5:03 pm | Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director | 980 | $9.04 | $8,859 | 31,304 (Indirect Direct) | View |
| 2024-02-23 Sale | 2024-02-27 5:02 pm | Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director | 980 | $9.04 | $8,859 | 0 (Direct) | View |
| 2023-06-12 Purchase | 2023-06-14 4:00 pm | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 28,000 | $0.35086 | $9,824 | 94,726 (Direct) | View |
| 2023-04-13 Purchase | 2023-04-17 06:00 am | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 150,000 | $0.29286 | $43,930 | 763,176 (Indirect Direct) | View |
| 2023-04-12 Purchase | 2023-04-14 6:02 pm | Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer | 25,000 | $0.288 | $7,200 | 164,676 (Direct) | View |
| 2023-04-12 Purchase | 2023-04-14 06:00 am | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 25,000 | $0.29 | $7,250 | 106,901 (Direct) | View |
| 2023-04-13 Purchase | 2023-04-14 06:00 am | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 30,000 | $0.2987 | $8,961 | 163,219 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 34,600 | $0 | 34,600 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 14,200 | $0 | 14,200 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh CTO/CSO | 17,700 | $0 | 17,700 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer | 14,200 | $0 | 14,200 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 14,200 | $0 | 14,200 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technical Officer | 11,838 | $0.4961 | 44,019 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer | 19,742 | $0.4961 | 128,635 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 8,868 | $0.4961 | 147,282 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 11,838 | $0.4961 | 84,758 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 55,440 | $0.4961 | 655,737 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:01 pm | N/A 2031-04-29 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 594,269 | $0 | 594,269 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 5:01 pm | N/A 2031-04-29 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 359,269 | $0 | 594,269 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:01 pm | N/A 2031-04-29 | Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer | 782,075 | $0 | 782,075 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 5:01 pm | N/A 2031-04-29 | Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer | 711,475 | $0 | 782,075 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:00 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 2,601,140 | $0 | 2,591,380 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 5:00 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 2,601,140 | $0 | 2,591,380 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 4:59 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 738,467 | $0 | 738,467 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 4:59 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 738,449 | $0 | 738,467 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 4:59 pm | N/A 2029-08-12 | Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technical Officer | 713,270 | $0 | 713,270 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 4:59 pm | N/A 2029-08-12 | Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technical Officer | 713,270 | $0 | 713,270 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:59 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 51,999 | $0.36 | 711,177 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:59 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 10,305 | $0.36 | 96,596 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:58 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 7,069 | $0.36 | 156,150 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:58 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer | 16,299 | $0.36 | 148,377 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:57 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technology Officer | 10,897 | $0.36 | 55,857 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | CARTER MICHAEL G Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | LARUE WILLIAM R Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | MAZANET ROSEMARY Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | Nakanishi Xin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | KISNER DANIEL L Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | DeSimone Jill Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-24 4:00 pm | N/A 2033-02-21 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer | 757,196 | $0 | 757,196 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 8:01 pm | N/A 2033-02-21 | Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer | 210,000 | $0 | 210,000 (Direct) | View |